Anne-Karin Gulbrandsen

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology

Vidar M. Steen, Ole A. Andreassen, Ann K. Daly et al. · Pharmacogenetics · 1995 · 243 citations

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

Ole A. Andreassen, Tom MacEwan, Anne-Karin Gulbrandsen et al. · Psychopharmacology · 1997 · 99 citations

Schizophrenic Patients, Neuroleptic-induced Movement Disorders, Psychiatry +13

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness

Vidar M. Steeir, Roger L vlie, Yamima Osher et al. · Pharmacogenetics · 1998 · 91 citations

Lithium Salts, Psychiatry, Mood Symptom +14

Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of the human cytochrome P450 CYP2D6 gene

Vidar M. Steen, Anders Molven, Nina Karin Aarskog et al. · Human Molecular Genetics · 1995 · 74 citations

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients

Gry Sjøholt, Anne-Karin Gulbrandsen, Roger Løvlie et al. · Molecular Psychiatry · 2000 · 55 citations

Putative Susceptibility Region, Polymorphism Screening, Psychiatry +10